In a report released yesterday, Richard Vosser from J.P. Morgan maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with a price target of CHF360.00. The company’s shares closed last Tuesday at $374.72.
Vosser has an average return of 13.8% when recommending Roche Holding AG.
According to TipRanks.com, Vosser is ranked #412 out of 7641 analysts.
Roche Holding AG has an analyst consensus of Moderate Buy, with a price target consensus of $409.32, representing a 9.5% upside. In a report issued on September 7, UBS also maintained a Hold rating on the stock with a CHF350.00 price target.
The company has a one-year high of $411.44 and a one-year low of $308.57. Currently, Roche Holding AG has an average volume of 4,836.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.